Tannic Acid
FDA-approved product (injectable, injection).
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLNo approved indication recorded
ChEMBL records no approved indication for Tannic Acid. Its therapeutic class is shown instead.
- Anti-infective classification
- Neither a WHO ATC code nor an FDA pharmacologic class was found for it, so whether it is already an antimicrobial is not established. It needs review and is not counted as a repurposing candidate.
Repurposing investigation
Tannic Acid reaches ≥40% AI-predicted activity against MRSA, but no WHO ATC code or FDA pharmacologic class says whether it is already an antimicrobial. It needs review, so it is not counted among the repurposing candidates.
AI-predicted activity
AI prediction · nothing measured- MRSA42.5% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli27.3% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae22.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis34.5% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Tannic Acid with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- AfamelanotideExisting use: Erythropoietic protoporphyria65.1% AI-predicted activityagainst MRSA23 registered studies
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives64.9% AI-predicted activityagainst MRSALab records exist50+ registered studies
- Imatinib MesylateExisting use: Acute lymphoblastic leukemia, B-cell acute lymphoblastic leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and 7 more64.9% AI-predicted activityagainst MRSA50+ registered studies
- Naldemedine TosylateExisting use: Constipation, Constipation disorder64.8% AI-predicted activityagainst MRSA1 registered study
- Vorapaxar SulfateExisting use: Myocardial infarction, Peripheral arterial disease, Recurrent thrombophlebitis and 1 more64.8% AI-predicted activityagainst MRSA15 registered studies
- Rimegepant SulfateExisting use: Migraine disorder64.7% AI-predicted activityagainst MRSA50+ registered studies
- Terlipressin AcetateExisting use: Hepatorenal syndrome, Kidney failure, Renal insufficiency64.6% AI-predicted activityagainst MRSA7 registered studies
- Bremelanotide AcetateExisting use: Mental or behavioural disorder, Physiological sexual disorder, Sexual dysfunction64.5% AI-predicted activityagainst MRSA1 registered study
- Tazemetostat HydrobromideExisting use: Follicular lymphoma, Neoplasm, Sarcoma64.4% AI-predicted activityagainst MRSA3 registered studies
- Isavuconazonium SulfateExisting use: Aspergillosis, Mucormycosis64.3% AI-predicted activityagainst MRSA50+ registered studies
- Nirogacestat HydrobromideExisting use: Gastrointestinal desmoid tumor64.2% AI-predicted activityagainst MRSA1 registered study
- Prasugrel HydrochlorideExisting use: Acute coronary syndrome, Hemorrhage, Intermediate coronary syndrome and 1 more64.2% AI-predicted activityagainst MRSA50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Evaluation of the Beneficial Effects of a Probiotic Product in Healthy Adult Subjects.
NCT03234452 · start 2016-03-23
Registered record
- Registry ID
- NCT03234452
- Conditions
- Disbiosis; Abdominal Pain; Constipation; Diarrhea; Stress
- Interventions
- Lactoflorene plus; Placebo Lactoflorene plus
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-03-23
- Completion
- 2017-04-18
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDisbiosis; Abdominal Pain; Constipation; Diarrhea +1 moreInterventionLactoflorene plus; Placebo Lactoflorene plusPhaseNot applicableRegistry statusCompletedComparison of Two Nutrition Interventions in Young Children in El Salvador
NCT02567981 · start 2015-09
Registered record
- Registry ID
- NCT02567981
- Conditions
- Micronutrient Deficiency
- Interventions
- 21 micronutrient-fortified supplement; Cereal Fortificado (Fortified Cereal); Ferrous sulphate; Vitamin A
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2015-09
- Completion
- 2020-09
- Enrolment
- 4,577
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMicronutrient DeficiencyIntervention21 micronutrient-fortified supplement; Cereal Fortificado (Fortified Cereal); Ferrous sulphate; Vitamin APhaseNot applicableRegistry statusUnknownImpact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.
NCT02031289 · start 2013-12
Registered record
- Registry ID
- NCT02031289
- Conditions
- Anemia; Iron Deficiency
- Interventions
- Erythropoietin/Ferric carboxymaltose/Vitamin B12/Folic Acid
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2013-12
- Completion
- 2018-05
- Enrolment
- 1,003
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnemia; Iron DeficiencyInterventionErythropoietin/Ferric carboxymaltose/Vitamin B12/Folic AcidPhasePhase 4Registry statusCompletedMother-caregivers of Children With Duchenne Muscular Dystrophy
NCT01921374 · start 2013-08
Registered record
- Registry ID
- NCT01921374
- Conditions
- Other Diseases or Conditions
- Interventions
- sleep parameters; Hormonal profile; Inflammatory profile; Cardiovascular profile; Metabolic profile
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2013-08
- Completion
- 2014-07
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionOther Diseases or ConditionsInterventionsleep parameters; Hormonal profile; Inflammatory profile; Cardiovascular profile +1 morePhaseNot applicableRegistry statusCompletedA Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients
NCT01594541 · start 2013-01
Registered record
- Registry ID
- NCT01594541
- Conditions
- Mild Cognitive Impairment
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Unknown
- Start
- 2013-01
- Completion
- 2014-04
- Enrolment
- 700
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMild Cognitive ImpairmentInterventionNot recordedPhaseNot recordedRegistry statusUnknownCervical Preparation Before Dilation and Evacuation
NCT01751087 · start 2013-01
Registered record
- Registry ID
- NCT01751087
- Conditions
- Abortion, Induced
- Interventions
- Mifepristone; misoprostol; Osmotic dilators; placebo; placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2013-01
- Completion
- 2014-06
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAbortion, InducedInterventionMifepristone; misoprostol; Osmotic dilators; placebo +1 morePhaseNot applicableRegistry statusCompletedEffect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
NCT01745198 · start 2012-12
Registered record
- Registry ID
- NCT01745198
- Conditions
- Mild Cognitive Impairment; Alzheimer's Disease; Alzheimer's Disease Related Disorders
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2012-12
- Completion
- 2014-06
- Enrolment
- 121
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMild Cognitive Impairment; Alzheimer's Disease; Alzheimer's Disease Related DisordersInterventionNot recordedPhaseNot recordedRegistry statusCompletedTrace Element Replenishment Study in Hemodialysis Patients
NCT01473914 · start 2012-11
Registered record
- Registry ID
- NCT01473914
- Conditions
- End Stage Renal Disease
- Interventions
- Low dose: supplemental zinc, selenium and vitamin E; Standard renal vitamin: B and C renal vitamin; Medium dose: supplemental zinc, selenium and vitamin E
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2012-11
- Completion
- 2014-01
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEnd Stage Renal DiseaseInterventionLow dose: supplemental zinc, selenium and vitamin E; Standard renal vitamin: B and C renal vitamin; Medium dose: supplemental zinc, selenium and vitamin EPhasePhase 3Registry statusCompletedA Nutritional Intervention for Diabetic Neuropathy
NCT01690962 · start 2012-11
Registered record
- Registry ID
- NCT01690962
- Conditions
- Diabetic Neuropathy
- Interventions
- Vegan diet and vitamin B12 supplement; Vitamin B12 supplement
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2012-11
- Completion
- 2014-02
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDiabetic NeuropathyInterventionVegan diet and vitamin B12 supplement; Vitamin B12 supplementPhaseNot applicableRegistry statusCompletedTo Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG)
NCT01474044 · start 2011-08
Registered record
- Registry ID
- NCT01474044
- Conditions
- Chronic Atrophic Gastritis (CAG)
- Interventions
- Gastropylor Complex Capsules; Placebo Comparator
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2011-08
- Completion
- 2013-02
- Enrolment
- 851
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Atrophic Gastritis (CAG)InterventionGastropylor Complex Capsules; Placebo ComparatorPhasePhase 4Registry statusCompletedA Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
NCT01057589 · start 2010-02
Registered record
- Registry ID
- NCT01057589
- Conditions
- Head and Neck Neoplasms
- Interventions
- Pemetrexed; Cetuximab; Cisplatin; Folic Acid; Vitamin B12
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2010-02
- Completion
- 2012-10
- Enrolment
- 66
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHead and Neck NeoplasmsInterventionPemetrexed; Cetuximab; Cisplatin; Folic Acid +1 morePhasePhase 2Registry statusCompletedEffect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People (KnoVIB)
NCT02586181 · start 2009-08
Registered record
- Registry ID
- NCT02586181
- Conditions
- Nutritional Supplement Toxicity
- Interventions
- Vitamin D and Calcium; Vitamin D, Calcium, Vitamins B9, B6, B12
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2009-08
- Completion
- 2011-07
- Enrolment
- 93
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionNutritional Supplement ToxicityInterventionVitamin D and Calcium; Vitamin D, Calcium, Vitamins B9, B6, B12PhaseNot applicableRegistry statusCompletedMicronutrient Supplementation in in Paediatric Pulmonary Tuberculosis
NCT00801606 · start 2008-12
Registered record
- Registry ID
- NCT00801606
- Conditions
- Tuberculosis
- Interventions
- Zinc; Micronutrient without zinc; Micronutrient with zinc; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2008-12
- Completion
- 2012-06
- Enrolment
- 403
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTuberculosisInterventionZinc; Micronutrient without zinc; Micronutrient with zinc; PlaceboPhasePhase 3Registry statusCompletedCobalamin Status in Young Children With Gastrointestinal Symptoms or Feeding Problems
NCT00710359 · start 2008-04
Registered record
- Registry ID
- NCT00710359
- Conditions
- Vitamin B 12 Deficiency
- Interventions
- Hydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2008-04
- Completion
- 2010-08
- Enrolment
- 100
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin B 12 DeficiencyInterventionHydroxycobalamin (Vitamin B12 Depot, Nycomed Pharma)PhaseNot applicableRegistry statusCompletedA Trial of Vitamins and HAART in HIV Disease Progression
NCT00383669 · start 2006-11
Registered record
- Registry ID
- NCT00383669
- Conditions
- HIV Infections
- Interventions
- Multivitamins (including B, C and E); Multivitamins B, C and E
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2006-11
- Completion
- 2009-10
- Enrolment
- 4,012
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHIV InfectionsInterventionMultivitamins (including B, C and E); Multivitamins B, C and EPhasePhase 3Registry statusCompleted